Joon Lee
Stock Analyst
(4.75)
# 2,543
Out of 4,648 analysts
109
Total ratings
59.15%
Success rate
44.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Buy | $540 → $660 | $583.66 | +13.08% | 11 | Oct 31, 2024 | |
| SAGE Sage Therapeutics | Maintains: Hold | $13 → $8 | $6.01 | +33.11% | 11 | Oct 30, 2024 | |
| CRMD CorMedix | Maintains: Buy | $12 → $17 | $9.82 | +73.12% | 7 | Oct 22, 2024 | |
| LBPH Longboard Pharmaceuticals | Downgrades: Hold | $60 | $59.53 | +0.79% | 2 | Oct 15, 2024 | |
| VRNA Verona Pharma | Maintains: Buy | $38 → $44 | $38.17 | +15.27% | 5 | Oct 9, 2024 | |
| CORT Corcept Therapeutics | Maintains: Buy | $65 → $76 | $51.08 | +48.79% | 7 | Sep 30, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $118 → $90 | $65.89 | +36.60% | 2 | Sep 17, 2024 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $60 → $40 | $7.70 | +419.48% | 6 | Aug 14, 2024 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $120 → $100 | $51.35 | +94.74% | 4 | Aug 12, 2024 | |
| CPRX Catalyst Pharmaceuticals | Maintains: Buy | $25 → $30 | $21.85 | +37.33% | 6 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $3.00 | +300.00% | 6 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $508 → $550 | $471.72 | +16.60% | 1 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 | $15.03 | +698.40% | 3 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 | $0.32 | +3,070.58% | 7 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 | $66.81 | +79.61% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 | $71.13 | +110.88% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $13.99 | +21.52% | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 | $88.23 | +70.02% | 2 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $27.29 | +138.18% | 5 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $110.30 | +81.32% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $1.45 | +246.02% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $6.91 | +160.33% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $2.92 | +9,485.43% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $20.29 | +67.57% | 1 | Mar 16, 2021 |
argenx SE
Oct 31, 2024
Maintains: Buy
Price Target: $540 → $660
Current: $583.66
Upside: +13.08%
Sage Therapeutics
Oct 30, 2024
Maintains: Hold
Price Target: $13 → $8
Current: $6.01
Upside: +33.11%
CorMedix
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $9.82
Upside: +73.12%
Longboard Pharmaceuticals
Oct 15, 2024
Downgrades: Hold
Price Target: $60
Current: $59.53
Upside: +0.79%
Verona Pharma
Oct 9, 2024
Maintains: Buy
Price Target: $38 → $44
Current: $38.17
Upside: +15.27%
Corcept Therapeutics
Sep 30, 2024
Maintains: Buy
Price Target: $65 → $76
Current: $51.08
Upside: +48.79%
BioMarin Pharmaceutical
Sep 17, 2024
Maintains: Buy
Price Target: $118 → $90
Current: $65.89
Upside: +36.60%
Adverum Biotechnologies
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $7.70
Upside: +419.48%
CRISPR Therapeutics AG
Aug 12, 2024
Maintains: Buy
Price Target: $120 → $100
Current: $51.35
Upside: +94.74%
Catalyst Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $25 → $30
Current: $21.85
Upside: +37.33%
Aug 8, 2024
Maintains: Buy
Price Target: $20 → $12
Current: $3.00
Upside: +300.00%
Aug 5, 2024
Reiterates: Buy
Price Target: $508 → $550
Current: $471.72
Upside: +16.60%
Jun 24, 2024
Maintains: Buy
Price Target: $120
Current: $15.03
Upside: +698.40%
Jun 18, 2024
Maintains: Buy
Price Target: $10
Current: $0.32
Upside: +3,070.58%
Jun 17, 2024
Maintains: Buy
Price Target: $120
Current: $66.81
Upside: +79.61%
May 16, 2024
Maintains: Buy
Price Target: $150
Current: $71.13
Upside: +110.88%
Apr 1, 2024
Reiterates: Buy
Price Target: $17
Current: $13.99
Upside: +21.52%
Mar 26, 2024
Maintains: Buy
Price Target: $150
Current: $88.23
Upside: +70.02%
Mar 25, 2024
Reiterates: Buy
Price Target: $65
Current: $27.29
Upside: +138.18%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $110.30
Upside: +81.32%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $1.45
Upside: +246.02%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $6.91
Upside: +160.33%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $2.92
Upside: +9,485.43%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $20.29
Upside: +67.57%